Healthcare and Medical Equipment
Expertise in pharmaceuticals sales, marketing and external affairs strategies and tactics.
1999 - Present
- Lead all matters pertaining to Aegerion Canada, the already incorporated subsidiary/Legal Entity and License-Holder for Juxtapid in the country.
- Lead the development of the global brand strategies and tactics for MACI (Matrix-induced autologous chondrocyte implant) and provide guidance on the execution of key marketing tactics in countries where MACI is commercially available.
- Was responsible for the successful launch of MYOZYME in the US and Global markets.